Stanley Druckenmiller acquired 2.38M Teva- Pharmaceutical Industries shares worth $76.1M. That's 2.38% of their equity portfolio (11th largest holding). The first Teva- Pharmaceutical Industries trade was made in Q4 2013. Since then Stanley Druckenmiller bought shares six more times and sold shares on four occasions. The stake costed the investor $42.7M, netting the investor a gain of 78% so far.